HFA Premium Access

Changing the treatment paradigm of hyperkalaemia management to enable and optimize renin-angiotensin-aldosterone system inhibitors therapy.

logo

Congress Presentation

About the speaker

Professor Bertram Pitt

University of Michigan, Ann Arbor (United States of America)
22 presentations
0 follower

4 more presentations in this session

Dilemma in cardio-renal patients: hyperkalaemia vs renin-angiotensin-aldosterone system inhibitors? - Introduction

Speaker: Professor J. Cleland (Glasgow, GB)

Thumbnail

Renin-angiotensin-aldosterone system inhibitors therapy benefits and challenges in cardio-renal patients.

Speaker: Professor P. Van Der Meer (Groningen, NL)

Thumbnail

Panel discussion.

Speaker: Professor J. Butler (Dallas, US)

Thumbnail

Dilemma in cardio-renal patients: hyperkalaemia vs renin-angiotensin-aldosterone system inhibitors? - Summary and conclusions

Speaker: Professor J. Cleland (Glasgow, GB)

Thumbnail

Access the full session

Dilemma in cardio-renal patients: hyperkalaemia vs renin-angiotensin-aldosterone system inhibitors?

Speakers: Professor B. Pitt, Professor J. Cleland, Professor P. Van Der Meer, Professor J. Butler, Professor J. Cleland
Thumbnail

About the event

Image

Heart Failure 2018

26 May - 29 May 2018

Sessions Presentations

ESC 365 is supported by

logo Novo Nordisk
logo Bristol Myers Squibb